Literature DB >> 18057092

Insulin internalizes GLUT2 in the enterocytes of healthy but not insulin-resistant mice.

Vanessa Tobin1, Maude Le Gall, Xavier Fioramonti, Emilie Stolarczyk, Alba G Blazquez, Christophe Klein, Magali Prigent, Patricia Serradas, Marie-Hélène Cuif, Christophe Magnan, Armelle Leturque, Edith Brot-Laroche.   

Abstract

OBJECTIVES: A physiological adaptation to a sugar-rich meal is achieved by increased sugar uptake to match dietary load, resulting from a rapid transient translocation of the fructose/glucose GLUT2 transporter to the brush border membrane (BBM) of enterocytes. The aim of this study was to define the contributors and physiological mechanisms controlling intestinal sugar absorption, focusing on the action of insulin and the contribution of GLUT2-mediated transport. RESEARCH DESIGN AND METHODS: The studies were performed in the human enterocytic colon carcinoma TC7 subclone (Caco-2/TC7) cells and in vivo during hyperinsulinemic-euglycemic clamp experiments in conscious mice. Chronic high-fructose or high-fat diets were used to induce glucose intolerance and insulin resistance in mice. RESULTS AND
CONCLUSIONS: In Caco-2/TC7 cells, insulin action diminished the transepithelial transfer of sugar and reduced BBM and basolateral membrane (BLM) GLUT2 levels, demonstrating that insulin can target sugar absorption by controlling the membrane localization of GLUT2 in enterocytes. Similarly, in hyperinsulinemic-euglycemic clamp experiments in sensitive mice, insulin abolished GLUT2 (i.e., the cytochalasin B-sensitive component of fructose absorption), decreased BBM GLUT2, and concomitantly increased intracellular GLUT2. Acute insulin treatment before sugar intake prevented the insertion of GLUT2 into the BBM. Insulin resistance in mice provoked a loss of GLUT2 trafficking, and GLUT2 levels remained permanently high in the BBM and low in the BLM. We propose that, in addition to its peripheral effects, insulin inhibits intestinal sugar absorption to prevent excessive blood glucose excursion after a sugar meal. This protective mechanism is lost in the insulin-resistant state induced by high-fat or high-fructose feeding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057092     DOI: 10.2337/db07-0928

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  38 in total

Review 1.  Comparative digestive physiology.

Authors:  William H Karasov; Angela E Douglas
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

2.  High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in mice.

Authors:  Juliane Zemdegs; Gaël Quesseveur; David Jarriault; Luc Pénicaud; Xavier Fioramonti; Bruno P Guiard
Journal:  Br J Pharmacol       Date:  2015-12-09       Impact factor: 8.739

3.  Intraintestinal and Parenteral Administration of an Insulin Analogue Leads to Comparable Activation of Signaling Downstream of the Insulin Receptor in the Small Intestine.

Authors:  Henning Hvid; Jonas Kildegaard; Kim Kristensen; Trine Porsgaard; Mikkel S Jørgensen; Borja Ballarín-González; Jonas Ahnfelt-Rønne; Bo F Hansen; Erica Nishimura
Journal:  J Diabetes Sci Technol       Date:  2019-06-12

Review 4.  Glucose transporters in the small intestine in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-23       Impact factor: 3.657

5.  Effects of octreotide on glucose transporter type 2 expression in obese rat small intestine.

Authors:  Na Wei; Rui Liu; Yan Ou; Xian Li; Ou Qiang; Wei Guo; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

6.  Hepatocyte nuclear factor 1 coordinates multiple processes in a model of intestinal epithelial cell function.

Authors:  Rui Yang; Jenny L Kerschner; Ann Harris
Journal:  Biochim Biophys Acta       Date:  2016-02-06

7.  Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity.

Authors:  H Honka; J Mäkinen; J C Hannukainen; M Tarkia; V Oikonen; M Teräs; V Fagerholm; T Ishizu; A Saraste; C Stark; T Vähäsilta; P Salminen; A Kirjavainen; M Soinio; A Gastaldelli; J Knuuti; P Iozzo; P Nuutila
Journal:  Diabetologia       Date:  2013-01-20       Impact factor: 10.122

Review 8.  The SLC2 (GLUT) family of membrane transporters.

Authors:  Mike Mueckler; Bernard Thorens
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

9.  The loss of P2X7 receptor expression leads to increase intestinal glucose transit and hepatic steatosis.

Authors:  Guillaume Arguin; Jean-François Bourzac; Morgane Placet; Caroline M Molle; Michel Paquette; Jean-François Beaudoin; Jacques A Rousseau; Roger Lecomte; Mélanie Plourde; Fernand-Pierre Gendron
Journal:  Sci Rep       Date:  2017-10-10       Impact factor: 4.379

10.  Resistin-like molecule-beta inhibits SGLT-1 activity and enhances GLUT2-dependent jejunal glucose transport.

Authors:  Rim Belharbi Krimi; Philippe Letteron; Pia Chedid; Corinne Nazaret; Robert Ducroc; Jean-Claude Marie
Journal:  Diabetes       Date:  2009-06-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.